1.
Singh A, Isher J, Sehgal R, Manju, Kumari N, Kaur K. Molnupiravir and Favipiravir in the therapeutics of SARS-CoV-2 - A review. Indian J Pharm Drug Studies. 2022;1(3):73-78. Accessed November 15, 2026. https://mansapublishers.com/ijpds/article/view/3575